Circulating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis.

Circulating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis.

Item
http://www.wikidata.org/entity/Q34568353
Type X collagen levels are elevated in serum from human osteoarthritis patients and associated with biomarkers of cartilage degradation and inflammationBiomarkers for diagnosis, monitoring of progression, and treatment responses in ankylosing spondylitis and axial spondyloarthritis.Neo-Epitopes--Fragments of Cartilage and Connective Tissue Degradation in Early Rheumatoid Arthritis and Unclassified ArthritisInsight on Bone Morphogenetic Protein 7 in Ankylosing Spondylitis and its association with disease activity and radiographic damage.A critical evaluation of the role of subcutaneous abatacept in the treatment of rheumatoid arthritis: patient considerations.Redox proteomics gives insights into the role of oxidative stress in alkaptonuria.Review article: the efficacy of biomarkers in chronic fibroproliferative diseases - early diagnosis and prognosis, with liver fibrosis as an exemplar.Current serological possibilities for the diagnosis of arthritis with special focus on proteins and proteoglycans from the extracellular matrix.Biological relevance of citrullinations: diagnostic, prognostic and therapeutic options.Changes of patient-reported outcomes and protein fingerprint biomarkers after exercise therapy for axial spondyloarthritis.Inflammation (or synovitis)-driven osteoarthritis: an opportunity for personalizing prognosis and treatment?Cartilage collagen type II seromarker patterns in axial spondyloarthritis and psoriatic arthritis: associations with disease activity, smoking and HLA-B27.Serological biomarkers detect active joint destruction and inflammation in patients with haemophilic arthropathy.An update on biomarker discovery and use in axial spondyloarthritis.Intercritical circulating levels of neo-epitopes reflecting matrixmetalloprotease-driven degradation as markers of gout and frequent gout attacks.CRP and a biomarker of type I collagen degradation, C1M, can differentiate anti-inflammatory treatment response in ankylosing spondylitis.Osteoclasts degrade bone and cartilage knee joint compartments through different resorption processes.
P2860

Circulating protein fragments of cartilage and connective tissue degradation are diagnostic and prognostic markers of rheumatoid arthritis and ankylosing spondylitis.

Item
http://www.wikidata.org/entity/Q34568353
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Circulating protein fragments ...... is and ankylosing spondylitis.
@ast
Circulating protein fragments ...... is and ankylosing spondylitis.
@en
Circulating protein fragments ...... is and ankylosing spondylitis.
@nl
type
label
Circulating protein fragments ...... is and ankylosing spondylitis.
@ast
Circulating protein fragments ...... is and ankylosing spondylitis.
@en
Circulating protein fragments ...... is and ankylosing spondylitis.
@nl
prefLabel
Circulating protein fragments ...... is and ankylosing spondylitis.
@ast
Circulating protein fragments ...... is and ankylosing spondylitis.
@en
Circulating protein fragments ...... is and ankylosing spondylitis.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P932
P356
P1433
P1476
Circulating protein fragments ...... is and ankylosing spondylitis.
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0054504
P407
P433
P478
P50
P577
P5875
P698
P921
P932